The Chemours Company Reports Fourth Quarter and Full Year 2025 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Chemours (CC) Misses Q4 EPS by 2c, Beats on Revenue; Offers Guidance
February 19, 2026 4:39 PM ESTChemours (NYSE: CC) reported Q4 EPS of $0.05, $0.02 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.33 billion.
Key Full Year 2026 Outlook5
Consolidated Net Sales growth in the range of 3 to 5%
Adjusted EBITDA between $800... More
